OVERLAND PARK, Kan., Feb. 5 /PRNewswire/ -- Physicians Reference Laboratory ("PRL") announced today that it has developed the most comprehensive, commercially available HPV test to date. Under the marketed name COMPLeTe Care HPV, the test allows for early detection and differentiation between all 15 high risk types of HPV which can lead to cervical cancer.
Worldwide, cervical cancer is the second most common form of female cancer with an incidence of over 500,000 new cases and 300,000 deaths each year. If detected early, cervical cancer precursors can be treated effectively. Research worldwide has shown that virtually all cervical cancer is caused by human papillomavirus (HPV). Women persistently infected with certain carcinogenic types are at increased risk of developing severe dysplasia which can lead to cervical cancer.
According to PRL CEO, Spencer Kerley, M.D., "Of the over 100 HPV types, 15 are considered as high-risk for development of cervical cancer." Under the direction of Pradip Manna, Ph.D., Director of Molecular Diagnostics, PRL developed a test capable of specifically detecting all genomic variants of each high-risk HPV type. The specificity and accuracy of the test will help physicians better manage their patients' risk of developing cervical cancer.
"Women of all ages will benefit from PRL's COMPLeTe Care HPV. In addition to early detection, type differentiation can lead to higher success rates for HPV vaccines", said Dr. Kerley.
About Physicians Reference Laboratory
Physicians Reference Laboratory, LLC. is a privately owned, full-service diagnostic testing laboratory. For 30 years PRL has been renowned for incorporating new and innovative testing procedures and employing the most highly qualified professionals. By utilizing market leading technologies and providing expert service, PRL's focus is on efficiently delivering accurate diagnostic data to support the advancement of our customers' efforts, ultimately leading to the highest quality of patient care.
|SOURCE Physicians Reference Laboratory, LLC.|
Copyright©2008 PR Newswire.
All rights reserved